Abstract
Commercial penicillinases vary in their capacity to destroy penicillinase-resistant penicillins and cephalosporins. A new freeze-dried preparation containing both beta-lactamase I and II was found to inactivate all penicillins and cephalosporins at levels above those likely to be encountered in clinical specimens.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Newsom S. W. Treatment of staphylococcal endocarditis. Br Med J. 1967 Sep 9;3(5566):678–678. doi: 10.1136/bmj.3.5566.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newsom S. W., Walsingham B. M. The use of -lactamases in the clinical laboratory. J Med Microbiol. 1973 Feb;6(1):59–66. doi: 10.1099/00222615-6-1-59. [DOI] [PubMed] [Google Scholar]
- Stroy S. A., Preston D. A. Specific assay of aminoglycosidic- or polymyxin-type antibiotics present in human sera in combination with cephalosporins. Appl Microbiol. 1971 Jun;21(6):1002–1006. doi: 10.1128/am.21.6.1002-1006.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]